Now there are many (stages) where before there was one: In search of a pathophysiological classification of cirrhosis

Hepatology

Volumn 51, Issue 4, 2010, Pages 1445-1449

  Garcia Tsao, Guadalupe ^a   Friedman, Scott ^b   Iredale, John ^c   Pinzani, Massimo ^d  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

^d UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; ANTIFIBROTIC AGENT; ANTIVIRUS AGENT;

CLINICAL FEATURE; COMPENSATED LIVER CIRRHOSIS; DECOMPENSATED LIVER CIRRHOSIS; DISEASE CLASSIFICATION; HEMODYNAMICS; HEPATITIS B; HEPATITIS C; HISTOLOGY; HISTOPATHOLOGY; HUMAN; LIVER CIRRHOSIS; LIVER DISEASE; LIVER FIBROSIS; NONHUMAN; PATHOPHYSIOLOGY; PORTAL HYPERTENSION; PRIORITY JOURNAL; REVIEW;

ANIMALS; HEMODYNAMICS; HUMANS; LIVER CIRRHOSIS;

EID: 77950618947     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.23478     Document Type: Review

References (33)

1. Pinzani M, Rombouts K, Colagrande S. Fibrosis in chronic liver diseases: diagnosis and management. J Hepatol 2005;42(Suppl. 1):S22-S36.
2. Anthony PP, Ishak KG, Nayak NC, Poulsen HE, Scheuer PJ, Sobin LH. The morphology of cirrhosis. Recommendations on definition, nomenclature, and classification by a working group sponsored by the World Health Organization. J Clin Pathol 1978;31:395-414.
3. Poynard T, Bedossa P, Opolon P, for the OBSVIRC MCADg. Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet 1997;349:825-832.
4. Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995;22: 696-699.
5. Knodell RG, Ishak KG, Black WC, Craig R, Kaplowitz N,Kiernan TW, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. HEPATOL-OGY 1981;1:431-435.
6. Batts KP, Ludwig J. Chronic hepatitis. An update on terminology and reporting. Am J Surg Pathol 1995;19:1409-1417.
7. D'Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis. A systematic review of 118 studies. J Hepatol 2006;44:217-231.
8. Iwakiri Y, Groszmann RJ. Vascular endothelial dysfunction in cirrhosis. J Hepatol 2007;46:927-934.
9. Iwakiri Y, Groszmann RJ. The hyperdynamic circulation of chronic liver diseases: from the patient to the molecule. HEPATOLOGY 2006;43(2 Suppl. 1):S121-S131.
10. Groszmann RJ, Garcia-Tsao G, BoschJ, Grace ND, Burroughs AK, Planas R, et al. Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis. N Engl J Med 2005;353:2254-2261.
11. Ripoll C, Groszmann R, Garcia-Tsao G, Grace N, Burroughs A, Planas R, et al. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis. Gastroenterology 2007; 133:481-488.
12. Groszmann RJ, Bosch J, Grace N, Conn HO, Garcia-Tsao G, Navasa M, et al. Hemodynamic events in a prospective randomized trial of propran-olol vs placebo in the prevention of the first variceal hemorrhage. Gastro-enterology 1990;99:1401-1407.
13. Casado M, Bosch J, Garcia-Pagan JC, Bru C, Banares R, Bandi JC, et al. Clinical events after transjugular intrahepatic portosystemic shunt: correlation with hemodynamic findings. Gastroenterology 1998;114:1296-1303. (Pubitemid 28243916)
14. Bosch J, Garcia-Pagan JC. Prevention of variceal rebleeding. Lancet 2003; 361:952-954.
15. Moitinho E, Escorsell A, Bandi JC, Salmeron JM, Garcia-Pagan JC, Rodes J, et al. Prognostic value of early measurements of portal pressure in acute variceal bleeding. Gastroenterology 1999;117:626-631.
16. Ripoll C, Groszmann RJ, Garcia-Tsao G, Bosch J, Grace N, Burroughs A, et al. Hepatic venous pressure gradient predicts development of hepatocel-lular carcinoma independently of severity of cirrhosis. J Hepatol 2009;50: 923-928.
17. Krogsgaard K, Gluud C, Henriksen JH, Christoffersen P. Correlation between liver morphology and portal pressure in alcoholic liver disease. HEPATOLOGY 1984;4:699-703.
18. Van Leeuwen DJ, Howe SC, Scheuer PJ, Sherlock S. Portal hypertension in chronic hepatitis: relationship to morphological changes. Gut 1990;31: 339-343.
19. Blasco A, Forns X, Carrion JA, Garcia-Pagan JC, Gilabert R, Rimola A, et al. Hepatic venous pressure gradient identifies patients at risk of severe hepatitis C recurrence after liver transplantation. HEPATOLOGY 2006;43: 492-499.
20. Nagula S, Jain D, Groszmann RJ, Garcia-Tsao G. Histological-hemody-namic correlation in cirrhosis-a histological classification of the severity of cirrhosis. J Hepatol 2006;44:111-117.
21. Sreenivasan P, Inayat I, Jain D, Bari K, Garcia-Tsao G. Histological-clinical correlation in cirrhosis\Validation of a histological classification of the severity of cirrhosis [Abstract]. HEPATOLOGY 2007;46(Suppl. 1): 579A.
22. Viola A, Jain D, Garcia-Tsao G. Quantitative histological assessment in cirrhosis: septal thickness predicts clinical decompensation [Abstract]. J Hepatol 2009;50:S94.
23. Friedman SL. Mechanisms of hepatic fibrogenesis. Gastroenterology 2008;134:1655-1669.
24. Friedman SL, Bansal MB. Reversal of hepatic fibrosis-fact or fantasy? HEPATOLOGY 2006;43(2 Suppl 1):S82-S88.
25. Medina J, Arroyo AG, Sanchez-Madrid F, Moreno-Otero R. Angiogenesis in chronic inflammatory liver disease. HEPATOLOGY 2004;39:1185-1195.
26. Fernandez M, Semela D, Bruix J, Colle I, Pinzani M, Bosch J. Angiogen-esis in liver disease. J Hepatol 2009;50:604-620.
27. Mejias M, Garcia-Pras E, Tiani C, Miquel R, Bosch J, Fernandez M. Beneficial effects of sorafenib on splanchnic, intrahepatic, and portocollat-eral circulations in portal hypertensive and cirrhotic rats. HEPATOLOGY 2009;49:1245-1256.
28. Regev A, BerhoM, Jeffers LJ, Milikowski C, Molina EG, Pyrsopoulos NT, et al. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 2002;97:2614-2618.
29. Carrion JA, Navasa M, Bosch J, Bruguera M, Gilabert R, Forns X. Transient elastography for diagnosis of advanced fibrosis and portal hypertension in patients with hepatitis C recurrence after liver transplantation. Liver Transpl 2006;12:1791-1798.
30. Vizzutti F, Arena U, Romanelli RG, Rega L, Foschi M, ColagrandeS, et al. Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis. HEPATOLOGY 2007;45:1290-1297.
31. Lim JK, Groszmann RJ. Transient elastography for diagnosis of portal hypertension in liver cirrhosis: is there still a role for hepatic venous pressure gradient measurement? HEPATOLOGY 2007;45:1087-1090.
32. Bosch J. Predictions from a hard liver. J Hepatol 2006;45:174-177.
33. Vizzutti F, Arena U, Marra F, Pinzani M. Elastography for the non-invasive assessment of liver disease: limitations and future developments. Gut 2009;58:157-160.